M1 KLINIKEN AG (M12.DE) Stock Fundamental Analysis
FRA:M12 - Deutsche Boerse Ag - DE000A0STSQ8 - Common Stock - Currency: EUR
M12 gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 23 industry peers in the Health Care Providers & Services industry. Both the health and profitability get an excellent rating, making M12 a very profitable company, without any liquidiy or solvency issues. M12 is growing strongly while it is still valued neutral. This is a good combination! These ratings would make M12 suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
In the past year M12 was profitable.
M12 had a positive operating cash flow in the past year.
M12 had positive earnings in each of the past 5 years.
M12 had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
The Return On Assets of M12 (8.27%) is better than 96.15% of its industry peers.
M12 has a Return On Equity of 15.32%. This is amongst the best in the industry. M12 outperforms 88.46% of its industry peers.
With an excellent Return On Invested Capital value of 10.98%, M12 belongs to the best of the industry, outperforming 96.15% of the companies in the same industry.
M12 had an Average Return On Invested Capital over the past 3 years of 5.33%. This is in line with the industry average of 5.35%.
The last Return On Invested Capital (10.98%) for M12 is above the 3 year average (5.33%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.27% | ||
| ROE | 15.32% | ||
| ROIC | 10.98% |
ROA(3y)3.84%
ROA(5y)5.12%
ROE(3y)7.69%
ROE(5y)9.05%
ROIC(3y)5.33%
ROIC(5y)5.06%
1.3 Margins
M12 has a better Profit Margin (5.03%) than 80.77% of its industry peers.
In the last couple of years the Profit Margin of M12 has declined.
M12 has a better Operating Margin (6.87%) than 61.54% of its industry peers.
In the last couple of years the Operating Margin of M12 has declined.
Looking at the Gross Margin, with a value of 17.41%, M12 is in line with its industry, outperforming 42.31% of the companies in the same industry.
In the last couple of years the Gross Margin of M12 has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.87% | ||
| PM (TTM) | 5.03% | ||
| GM | 17.41% |
OM growth 3Y19.76%
OM growth 5Y-14.29%
PM growth 3Y-8.75%
PM growth 5Y-20.36%
GM growth 3Y-11.67%
GM growth 5Y-14.71%
2. Health
2.1 Basic Checks
M12 has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for M12 has been increased compared to 1 year ago.
M12 has more shares outstanding than it did 5 years ago.
The debt/assets ratio for M12 has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 4.77 indicates that M12 is not in any danger for bankruptcy at the moment.
The Altman-Z score of M12 (4.77) is better than 100.00% of its industry peers.
M12 has a debt to FCF ratio of 0.60. This is a very positive value and a sign of high solvency as it would only need 0.60 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.60, M12 belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
A Debt/Equity ratio of 0.07 indicates that M12 is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.07, M12 belongs to the best of the industry, outperforming 96.15% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 0.6 | ||
| Altman-Z | 4.77 |
ROIC/WACC1.59
WACC6.9%
2.3 Liquidity
A Current Ratio of 1.76 indicates that M12 should not have too much problems paying its short term obligations.
With an excellent Current ratio value of 1.76, M12 belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
M12 has a Quick Ratio of 1.10. This is a normal value and indicates that M12 is financially healthy and should not expect problems in meeting its short term obligations.
M12 has a better Quick ratio (1.10) than 88.46% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.76 | ||
| Quick Ratio | 1.1 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 163.63% over the past year.
The Earnings Per Share has been growing slightly by 5.87% on average over the past years.
The Revenue has grown by 12.05% in the past year. This is quite good.
Measured over the past years, M12 shows a very strong growth in Revenue. The Revenue has been growing by 37.14% on average per year.
EPS 1Y (TTM)163.63%
EPS 3Y12.51%
EPS 5Y5.87%
EPS Q2Q%189.66%
Revenue 1Y (TTM)12.05%
Revenue growth 3Y25.61%
Revenue growth 5Y37.14%
Sales Q2Q%11.24%
3.2 Future
M12 is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 39.45% yearly.
The Revenue is expected to grow by 9.46% on average over the next years. This is quite good.
EPS Next Y89.39%
EPS Next 2Y47.84%
EPS Next 3Y39.45%
EPS Next 5YN/A
Revenue Next Year12.09%
Revenue Next 2Y9.61%
Revenue Next 3Y9.23%
Revenue Next 5Y9.46%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 17.41 indicates a rather expensive valuation of M12.
Compared to the rest of the industry, the Price/Earnings ratio of M12 is on the same level as its industry peers.
M12's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 29.35.
Based on the Price/Forward Earnings ratio of 15.25, the valuation of M12 can be described as correct.
M12's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.10. M12 is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.41 | ||
| Fwd PE | 15.25 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of M12 is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of M12 indicates a somewhat cheap valuation: M12 is cheaper than 69.23% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.3 | ||
| EV/EBITDA | 9.88 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of M12 may justify a higher PE ratio.
A more expensive valuation may be justified as M12's earnings are expected to grow with 39.45% in the coming years.
PEG (NY)0.19
PEG (5Y)2.97
EPS Next 2Y47.84%
EPS Next 3Y39.45%
5. Dividend
5.1 Amount
M12 has a Yearly Dividend Yield of 3.41%.
M12's Dividend Yield is rather good when compared to the industry average which is at 2.93. M12 pays more dividend than 88.46% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.33, M12 pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.41% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y47.84%
EPS Next 3Y39.45%
FRA:M12 (3/7/2025, 7:00:00 PM)
14.8
+0.15 (+1.02%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners1.43%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap290.67M
Analysts85.71
Price Target28.05 (89.53%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.41% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)6.07%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.95%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.41 | ||
| Fwd PE | 15.25 | ||
| P/S | 0.87 | ||
| P/FCF | 8.3 | ||
| P/OCF | 8.01 | ||
| P/B | 2.66 | ||
| P/tB | 13.46 | ||
| EV/EBITDA | 9.88 |
EPS(TTM)0.85
EY5.74%
EPS(NY)0.97
Fwd EY6.56%
FCF(TTM)1.78
FCFY12.05%
OCF(TTM)1.85
OCFY12.48%
SpS16.97
BVpS5.57
TBVpS1.1
PEG (NY)0.19
PEG (5Y)2.97
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.27% | ||
| ROE | 15.32% | ||
| ROCE | 15.68% | ||
| ROIC | 10.98% | ||
| ROICexc | 12.98% | ||
| ROICexgc | 44.89% | ||
| OM | 6.87% | ||
| PM (TTM) | 5.03% | ||
| GM | 17.41% | ||
| FCFM | 10.51% |
ROA(3y)3.84%
ROA(5y)5.12%
ROE(3y)7.69%
ROE(5y)9.05%
ROIC(3y)5.33%
ROIC(5y)5.06%
ROICexc(3y)7.46%
ROICexc(5y)7.66%
ROICexgc(3y)20.1%
ROICexgc(5y)16.58%
ROCE(3y)7.61%
ROCE(5y)7.23%
ROICexcg growth 3Y47.1%
ROICexcg growth 5Y10.13%
ROICexc growth 3Y26.66%
ROICexc growth 5Y-7.94%
OM growth 3Y19.76%
OM growth 5Y-14.29%
PM growth 3Y-8.75%
PM growth 5Y-20.36%
GM growth 3Y-11.67%
GM growth 5Y-14.71%
F-Score8
Asset Turnover1.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 0.6 | ||
| Debt/EBITDA | 0.26 | ||
| Cap/Depr | 24.28% | ||
| Cap/Sales | 0.37% | ||
| Interest Coverage | 16.74 | ||
| Cash Conversion | 129.38% | ||
| Profit Quality | 209.01% | ||
| Current Ratio | 1.76 | ||
| Quick Ratio | 1.1 | ||
| Altman-Z | 4.77 |
F-Score8
WACC6.9%
ROIC/WACC1.59
Cap/Depr(3y)24.3%
Cap/Depr(5y)28.94%
Cap/Sales(3y)0.45%
Cap/Sales(5y)0.8%
Profit Quality(3y)264.65%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)163.63%
EPS 3Y12.51%
EPS 5Y5.87%
EPS Q2Q%189.66%
EPS Next Y89.39%
EPS Next 2Y47.84%
EPS Next 3Y39.45%
EPS Next 5YN/A
Revenue 1Y (TTM)12.05%
Revenue growth 3Y25.61%
Revenue growth 5Y37.14%
Sales Q2Q%11.24%
Revenue Next Year12.09%
Revenue Next 2Y9.61%
Revenue Next 3Y9.23%
Revenue Next 5Y9.46%
EBIT growth 1Y86.59%
EBIT growth 3Y50.43%
EBIT growth 5Y17.54%
EBIT Next Year101.33%
EBIT Next 3Y43.63%
EBIT Next 5YN/A
FCF growth 1Y68.01%
FCF growth 3Y71.63%
FCF growth 5Y106.11%
OCF growth 1Y62.27%
OCF growth 3Y57.15%
OCF growth 5Y48.73%